Ifp Advisors, Inc Purple Biotech Ltd. Transaction History

Ifp Advisors, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$2.39 - $4.15 $23 - $41	10 New	10 $1,000
Q2 2022 Aug 12, 2022	SELL	$2.39 - $4.15 $23 - $41	-10 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$2.45 - $4.3 $24 - $43	10 New	10 $0

19.3K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $46.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.